Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA

BACKGROUND: Since universal vaccinations represents the most effective strategy to mitigate coronavirus disease 2019 (COVID-19), baseline assessment and post-vaccine monitoring of anti-SARS-CoV-2 neutralizing antibodies are essential to vaccination programs. Therefore, this study aimed to compare da...

Descripción completa

Detalles Bibliográficos
Autores principales: Danese, Elisa, Montagnana, Martina, Salvagno, Gian Luca, Gelati, Matteo, Peserico, Denise, Pighi, Laura, de Nitto, Simone, Henry, Brandon M., Porru, Stefano, Lippi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Medical Biochemists of Serbia, Belgrade 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451228/
https://www.ncbi.nlm.nih.gov/pubmed/34616223
http://dx.doi.org/10.5937/jomb0-31475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451228/
https://www.ncbi.nlm.nih.gov/pubmed/34616223
http://dx.doi.org/10.5937/jomb0-31475

Ejemplares similares